Prior research has demonstrated that elevated expression of LONP1 in cancer enables cancer cells to resist oncogenic stressors, including hypoxia, protein damage, and oxidative stress, and alters energy metabolic pathways, thereby fostering malignant proliferation, tumor metastasis, and therapeutic resistance [19,38–40]. Here, LONP1 is linked to neoplasm.